Tumour necrosis factor-alpha depletes histone deacetylase 1 protein through IKK2.

No abstract is available for this paper.

• Publication year

  2006

• Venue

  EMBO Reports

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  PMID 16374504PMCID PMC1456891
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Histone deacetylase inhibitors: new drugs for the treatment of inflammatory diseases?

  2005cited by this paper
• Histone deacetylase inhibitors: assays to assess effectiveness in vitro and in vivo.

  2004cited by this paper
• Regulation of histone deacetylase activities

  2004cited by this paper
• Activating FOXO3a, NF-kappaB and p53 by targeting IKKs: An effective multi-faceted targeting of the tumor-cell phenotype?

  2004cited by this paper
• Histone deacetylases (HDACs): characterization of the classical HDAC family.

  2003cited by this paper
• Gene expression profiling of multiple histone deacetylase (HDAC) inhibitors: defining a common gene set produced by HDAC inhibition in T24 and MDA carcinoma cell lines.

  2003cited by this paper
• NF-kappaB regulation in the immune system.

  2002cited by this paper
• Essential function of histone deacetylase 1 in proliferation control and CDK inhibitor repression

  2002cited by this paper
• Exchange of N-CoR corepressor and Tip60 coactivator complexes links gene expression by NF-kappaB and beta-amyloid precursor protein.

  2002cited by this paper
• Acetylation and chromosomal functions.

  2000cited by this paper
• NF-kappa B and Rel proteins: evolutionarily conserved mediators of immune responses.

  1998cited by this paper
• WAF1, a potential mediator of p53 tumor suppression.

  1993cited by this paper
• Rapid detection of octamer binding proteins with 'mini-extracts', prepared from a small number of cells.

  1989cited by this paper

• Blockage of CacyBP inhibits macrophage recruitment and improves anti-PD-1 therapy in hepatocellular carcinoma

  2023cites this paper
• Epigenetic DNA Methylation of EBI3 Modulates Human Interleukin-35 Formation via NFkB Signaling: A Promising Therapeutic Option in Ulcerative Colitis

  2021influential citation
• HDAC1 inhibition ameliorates TDP-43-induced cell death in vitro and in vivo

  2020cites this paper
• NCoR1 Protects Mice From Dextran Sodium Sulfate–Induced Colitis by Guarding Colonic Crypt Cells From Luminal Insult

  2020cites this paper
• Histone Deacetylases Regulation by δ-Opioids in Human Optic Nerve Head Astrocytes

  2020cites this paper
• Collateral Sensitivity of Parthenolide via NF-κB and HIF-α Inhibition and Epigenetic Changes in Drug-Resistant Cancer Cell Lines

  2019cites this paper
• Activation of Class I histone deacetylases contributes to mitochondrial dysfunction in cardiomyocytes with altered complex activities

  2018cites this paper
• The transcriptional response of skin to fluorescent light exposure in viviparous (Xiphophorus) and oviparous (Danio, Oryzias) fishes.

  2017cites this paper
• Epigenetic Regulation of Early- and Late-Response Genes in Acute Pancreatitis

  2016cites this paper
• Histone deacetylase 5 regulates the inflammatory response of macrophages

  2015cites this paper
• Lysine Deacetylase (KDAC) Regulatory Pathways: an Alternative Approach to Selective Modulation

  2014cites this paper
• Helpful or Harmful? Potential Effects of Exercise on Select Inflammatory Conditions

  2013cites this paper
• Post-translational loss of renal TRPV5 calcium channel expression, Ca(2+) wasting, and bone loss in experimental colitis.

  2013cites this paper
• PKD2 and PKD3 promote prostate cancer cell invasion by modulating NF-&kgr;B- and HDAC1-mediated expression and activation of uPA

  2012influential citation
• Role of histone deacetylase 2 in epigenetics and cellular senescence: implications in lung inflammaging and COPD.

  2012cites this paper
• Apoptosis signalling activated by TNF in the lower gastrointestinal tract--review.

  2012cites this paper
• IKKβ Overexpression Leads to Pathologic Lesions in Stratified Epithelia and Exocrine Glands and to Tumoral Transformation of Oral Epithelia

  2011cites this paper
• Making Muscles Grow by G Protein–Coupled Receptor Signaling

  2011cites this paper
• Protected from the inside: endogenous histone deacetylase inhibitors and the road to cancer.

  2011cites this paper
• Genetic and epigenetic determinants of alcoholic liver disease

  2010cites this paper
• Chemopreventive agent 3,3'-diindolylmethane selectively induces proteasomal degradation of class I histone deacetylases.

  2010cites this paper
• Regulating the Regulators: The Post-Translational Code of Class I HDAC1 and HDAC2

  2010cites this paper
• Histone deacetylases and the immunological network: implications in cancer and inflammation

  2010cites this paper
• IKKbeta leads to an inflammatory skin disease resembling interface dermatitis.

  2010cites this paper
• Histone deacetylase 2 is phosphorylated, ubiquitinated, and degraded by cigarette smoke.

  2009cites this paper
• Transcriptional regulation of the pro-apoptotic gene Bnip3 by P65 NF-κB, Histone Deacetylase 1, and E2F-1 in postnatal ventricular myocytes

  2009cites this paper
• Parthenolide promotes the ubiquitination of MDM2 and activates p53 cellular functions

  2009cites this paper
• Histone deacetylases: salesmen and customers in the post‐translational modification market

  2009cites this paper
• Regulation of C/EBPdelta-dependent transactivation by histone deacetylases in intestinal epithelial cells.

  2008cites this paper
• Primers on Molecular Pathways

  2007cites this paper
• Postsynaptic chromatin is under neural control at the neuromuscular junction

  2007cites this paper
• The Molecular Bases of Training Adaptation

  2007cites this paper
• Parthenolide specifically depletes histone deacetylase 1 protein and induces cell death through ataxia telangiectasia mutated.

  2007cites this paper
• Depletion of Histone Deacetylase I Protein: A Common Consequence of Inflammatory Cytokine Signaling?

  2006cites this paper